Osteopontin levels in the serum reflect anatomical disease progression in patients with amyotrophic lateral sclerosis
{{output}}
Background: Amyotrophic lateral sclerosis (ALS) lacks biomarkers for diagnosis, prognostic stratification, and evaluation of response to potential treatments. Previous research supported the role of serum osteopontin (OPN) levels... ...
